Search

Farley J. Abad

Examiner (ID: 14201, Phone: (571)270-3425 , Office: P/2181 )

Most Active Art Unit
2181
Art Unit(s)
2181
Total Applications
1076
Issued Applications
864
Pending Applications
101
Abandoned Applications
140

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6729668 [patent_doc_number] => 20030185858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Immunogenic HBc chimer particles stabilized with an N-terminal cysteine' [patent_app_type] => new [patent_app_number] => 10/082014 [patent_app_country] => US [patent_app_date] => 2002-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 31673 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 297 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20030185858.pdf [firstpage_image] =>[orig_patent_app_number] => 10082014 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/082014
Immunogenic HBc chimer particles stabilized with an N-terminal cysteine Feb 20, 2002 Abandoned
Array ( [id] => 252375 [patent_doc_number] => 07579007 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-25 [patent_title] => 'Production of “biological carriers” for induction of immune responses and inhibition of viral replication' [patent_app_type] => utility [patent_app_number] => 10/468047 [patent_app_country] => US [patent_app_date] => 2002-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6978 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/579/07579007.pdf [firstpage_image] =>[orig_patent_app_number] => 10468047 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/468047
Production of “biological carriers” for induction of immune responses and inhibition of viral replication Feb 11, 2002 Issued
Array ( [id] => 6765706 [patent_doc_number] => 20030100106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-29 [patent_title] => 'Baculovirus produced Plasmodium falciparum vaccine' [patent_app_type] => new [patent_app_number] => 10/062809 [patent_app_country] => US [patent_app_date] => 2002-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 29002 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20030100106.pdf [firstpage_image] =>[orig_patent_app_number] => 10062809 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/062809
Baculovirus produced Plasmodium falciparum vaccine Jan 31, 2002 Abandoned
Array ( [id] => 6851046 [patent_doc_number] => 20030143249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Method of treating pain' [patent_app_type] => new [patent_app_number] => 10/062954 [patent_app_country] => US [patent_app_date] => 2002-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3768 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143249.pdf [firstpage_image] =>[orig_patent_app_number] => 10062954 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/062954
Method of treating pain Jan 30, 2002 Issued
Array ( [id] => 675539 [patent_doc_number] => 07087376 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-08 [patent_title] => 'Detection and identification of bacterial strains' [patent_app_type] => utility [patent_app_number] => 10/060618 [patent_app_country] => US [patent_app_date] => 2002-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4804 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/087/07087376.pdf [firstpage_image] =>[orig_patent_app_number] => 10060618 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/060618
Detection and identification of bacterial strains Jan 29, 2002 Issued
Array ( [id] => 6745646 [patent_doc_number] => 20030022829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Novel antiviral activities primate theta defensins and mammalian cathelicidins' [patent_app_type] => new [patent_app_number] => 10/060102 [patent_app_country] => US [patent_app_date] => 2002-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17030 [patent_no_of_claims] => 70 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022829.pdf [firstpage_image] =>[orig_patent_app_number] => 10060102 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/060102
Novel antiviral activities primate theta defensins and mammalian cathelicidins Jan 28, 2002 Abandoned
Array ( [id] => 930942 [patent_doc_number] => 06979446 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-27 [patent_title] => 'Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections' [patent_app_type] => utility [patent_app_number] => 10/056052 [patent_app_country] => US [patent_app_date] => 2002-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15665 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/979/06979446.pdf [firstpage_image] =>[orig_patent_app_number] => 10056052 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/056052
Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections Jan 27, 2002 Issued
09/914669 Herpes simplex virus reactivation model Jan 24, 2002 Abandoned
Array ( [id] => 455729 [patent_doc_number] => 07244438 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-17 [patent_title] => 'Uses for polycationic compounds' [patent_app_type] => utility [patent_app_number] => 10/250953 [patent_app_country] => US [patent_app_date] => 2002-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6190 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/244/07244438.pdf [firstpage_image] =>[orig_patent_app_number] => 10250953 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/250953
Uses for polycationic compounds Jan 6, 2002 Issued
09/937857 Influenza virus hemagglutinin-binding peptides Jan 3, 2002 Abandoned
Array ( [id] => 6683345 [patent_doc_number] => 20030119209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Diagnostic methods and devices' [patent_app_type] => new [patent_app_number] => 10/026314 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 11592 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119209.pdf [firstpage_image] =>[orig_patent_app_number] => 10026314 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/026314
Diagnostic methods and devices Dec 20, 2001 Abandoned
Array ( [id] => 6711810 [patent_doc_number] => 20030171559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'G-CSF analog compositions and methods' [patent_app_type] => new [patent_app_number] => 10/032108 [patent_app_country] => US [patent_app_date] => 2001-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 19704 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 53 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171559.pdf [firstpage_image] =>[orig_patent_app_number] => 10032108 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/032108
G-CSF analog compositions and methods Dec 19, 2001 Issued
Array ( [id] => 7219185 [patent_doc_number] => 20050260559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Assay for anti-viral agent' [patent_app_type] => utility [patent_app_number] => 10/450342 [patent_app_country] => US [patent_app_date] => 2001-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3803 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260559.pdf [firstpage_image] =>[orig_patent_app_number] => 10450342 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/450342
Assay for anti-viral agent Dec 11, 2001 Issued
Array ( [id] => 1085573 [patent_doc_number] => 06830917 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-14 [patent_title] => 'Method of isolation and purification of trypsin from pronase protease and use thereof' [patent_app_type] => B2 [patent_app_number] => 10/006223 [patent_app_country] => US [patent_app_date] => 2001-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9260 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/830/06830917.pdf [firstpage_image] =>[orig_patent_app_number] => 10006223 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/006223
Method of isolation and purification of trypsin from pronase protease and use thereof Dec 9, 2001 Issued
Array ( [id] => 7286641 [patent_doc_number] => 20040146854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Attenuated forms of bovine viral diarrhea virus' [patent_app_type] => new [patent_app_number] => 09/989933 [patent_app_country] => US [patent_app_date] => 2001-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10737 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146854.pdf [firstpage_image] =>[orig_patent_app_number] => 09989933 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/989933
Attenuated forms of bovine viral diarrhea virus Nov 20, 2001 Abandoned
Array ( [id] => 6017071 [patent_doc_number] => 20020103212 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-01 [patent_title] => 'Pharmaceutical compositions containing anti-fas antibody' [patent_app_type] => new [patent_app_number] => 09/989620 [patent_app_country] => US [patent_app_date] => 2001-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9073 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20020103212.pdf [firstpage_image] =>[orig_patent_app_number] => 09989620 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/989620
Pharmaceutical compositions containing anti-Fas antibody Nov 19, 2001 Issued
Array ( [id] => 6774258 [patent_doc_number] => 20030017596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Use of parvovirus capsid particles in the inhibition of cell proliferation and migration' [patent_app_type] => new [patent_app_number] => 09/991433 [patent_app_country] => US [patent_app_date] => 2001-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18006 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017596.pdf [firstpage_image] =>[orig_patent_app_number] => 09991433 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/991433
Use of parvovirus capsid particles in the inhibition of cell proliferation and migration Nov 15, 2001 Issued
Array ( [id] => 679144 [patent_doc_number] => 07083787 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-01 [patent_title] => 'Yeast-dendritic cell vaccines and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/991363 [patent_app_country] => US [patent_app_date] => 2001-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 20190 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/083/07083787.pdf [firstpage_image] =>[orig_patent_app_number] => 09991363 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/991363
Yeast-dendritic cell vaccines and uses thereof Nov 14, 2001 Issued
Array ( [id] => 7149912 [patent_doc_number] => 20040171132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'RECOMBINANT INFECTIOUS LARYNGOTRACHEITIS VIRUS AND USES THEREOF' [patent_app_type] => new [patent_app_number] => 09/993777 [patent_app_country] => US [patent_app_date] => 2001-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 24864 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171132.pdf [firstpage_image] =>[orig_patent_app_number] => 09993777 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/993777
Recombinant infectious laryngotracheitis virus and uses thereof Nov 5, 2001 Issued
Array ( [id] => 6870099 [patent_doc_number] => 20030082788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Recombinant infectious laryngotracheitis virus and uses thereof' [patent_app_type] => new [patent_app_number] => 09/994064 [patent_app_country] => US [patent_app_date] => 2001-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25282 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082788.pdf [firstpage_image] =>[orig_patent_app_number] => 09994064 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/994064
Recombinant infectious laryngotracheitis virus and uses thereof Nov 5, 2001 Issued
Menu